Strides Pharma board approves addnl USD 40 mn investment in Stelis Biopharma
Posted by
www.biotecnika.org
The company's board has approved an additional investment up to a
maximum of USD 40 million over a period of 24 months for a controlling
stake in Stelis, Strides Pharma Science said in a statement.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/strides-pharma-board-approves-addnl-usd-40-mn-investment-in-stelis-biopharma/articleshow/71219220.cms
Subscribe to:
Post Comments (Atom)
Post a Comment